

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 5.13077740 |
| 2 | central nervous system myelination (GO:0022010) | 5.13077740 |
| 3 | DNA unwinding involved in DNA replication (GO:0006268) | 5.00926071 |
| 4 | fatty acid elongation (GO:0030497) | 4.88211682 |
| 5 | nuclear pore complex assembly (GO:0051292) | 4.49640695 |
| 6 | C4-dicarboxylate transport (GO:0015740) | 4.37287666 |
| 7 | cholesterol biosynthetic process (GO:0006695) | 4.23549601 |
| 8 | COPI coating of Golgi vesicle (GO:0048205) | 4.23495585 |
| 9 | Golgi transport vesicle coating (GO:0048200) | 4.23495585 |
| 10 | pinocytosis (GO:0006907) | 4.07663909 |
| 11 | formation of translation preinitiation complex (GO:0001731) | 4.06449631 |
| 12 | nuclear pore organization (GO:0006999) | 3.99283923 |
| 13 | regulation of cholesterol homeostasis (GO:2000188) | 3.99242920 |
| 14 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.93946185 |
| 15 | protein maturation by protein folding (GO:0022417) | 3.84224569 |
| 16 | L-amino acid import (GO:0043092) | 3.83727927 |
| 17 | DNA strand elongation (GO:0022616) | 3.83378609 |
| 18 | mitotic chromosome condensation (GO:0007076) | 3.83112989 |
| 19 | L-phenylalanine catabolic process (GO:0006559) | 3.78793155 |
| 20 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.78793155 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 3.74319769 |
| 22 | pore complex assembly (GO:0046931) | 3.72200528 |
| 23 | sterol biosynthetic process (GO:0016126) | 3.70586418 |
| 24 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.68560222 |
| 25 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.68560222 |
| 26 | ribosomal small subunit biogenesis (GO:0042274) | 3.64380599 |
| 27 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.62986737 |
| 28 | L-phenylalanine metabolic process (GO:0006558) | 3.62986737 |
| 29 | negative regulation of digestive system process (GO:0060457) | 3.61643178 |
| 30 | amino acid import (GO:0043090) | 3.58578368 |
| 31 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.55749821 |
| 32 | regulation of translational fidelity (GO:0006450) | 3.52291407 |
| 33 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.49772678 |
| 34 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 3.49311274 |
| 35 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.47333094 |
| 36 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.44399244 |
| 37 | cysteine metabolic process (GO:0006534) | 3.43313845 |
| 38 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.40320130 |
| 39 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.39470634 |
| 40 | DNA replication initiation (GO:0006270) | 3.38403330 |
| 41 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.34831833 |
| 42 | very long-chain fatty acid metabolic process (GO:0000038) | 3.34607211 |
| 43 | cellular copper ion homeostasis (GO:0006878) | 3.32750017 |
| 44 | acyl-CoA biosynthetic process (GO:0071616) | 3.29132208 |
| 45 | thioester biosynthetic process (GO:0035384) | 3.29132208 |
| 46 | maturation of SSU-rRNA (GO:0030490) | 3.25609145 |
| 47 | negative regulation of B cell mediated immunity (GO:0002713) | 3.18811499 |
| 48 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.18811499 |
| 49 | myelination (GO:0042552) | 3.18585719 |
| 50 | cellular ketone body metabolic process (GO:0046950) | 3.17945536 |
| 51 | ensheathment of neurons (GO:0007272) | 3.16797808 |
| 52 | axon ensheathment (GO:0008366) | 3.16797808 |
| 53 | pentose-phosphate shunt (GO:0006098) | 3.15759632 |
| 54 | proline biosynthetic process (GO:0006561) | 3.15475195 |
| 55 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.14453178 |
| 56 | L-serine transport (GO:0015825) | 3.13163492 |
| 57 | L-serine metabolic process (GO:0006563) | 3.11381349 |
| 58 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.09810189 |
| 59 | ribosome biogenesis (GO:0042254) | 3.09321030 |
| 60 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.07980424 |
| 61 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.07401675 |
| 62 | ribosome assembly (GO:0042255) | 3.07323334 |
| 63 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.06109143 |
| 64 | glutamate metabolic process (GO:0006536) | 3.05074468 |
| 65 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.98938529 |
| 66 | sulfur amino acid catabolic process (GO:0000098) | 2.96416602 |
| 67 | amino-acid betaine metabolic process (GO:0006577) | 2.96105607 |
| 68 | neuron cell-cell adhesion (GO:0007158) | 2.95782648 |
| 69 | linoleic acid metabolic process (GO:0043651) | 2.95081418 |
| 70 | transcytosis (GO:0045056) | 2.94869847 |
| 71 | creatine metabolic process (GO:0006600) | 2.94107752 |
| 72 | establishment of integrated proviral latency (GO:0075713) | 2.89991292 |
| 73 | ribosomal small subunit assembly (GO:0000028) | 2.88764136 |
| 74 | regulation of translational termination (GO:0006449) | 2.88329606 |
| 75 | heme transport (GO:0015886) | 2.87795079 |
| 76 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.87636674 |
| 77 | mitotic nuclear envelope disassembly (GO:0007077) | 2.87167146 |
| 78 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.85621416 |
| 79 | serine family amino acid biosynthetic process (GO:0009070) | 2.84972241 |
| 80 | DNA topological change (GO:0006265) | 2.84006080 |
| 81 | DNA duplex unwinding (GO:0032508) | 2.82786592 |
| 82 | dosage compensation (GO:0007549) | 2.79754758 |
| 83 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.78797347 |
| 84 | telomere maintenance via recombination (GO:0000722) | 2.78763936 |
| 85 | short-chain fatty acid metabolic process (GO:0046459) | 2.78484765 |
| 86 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.77902711 |
| 87 | proteasome assembly (GO:0043248) | 2.77685709 |
| 88 | ketone body metabolic process (GO:1902224) | 2.76189568 |
| 89 | ribosomal large subunit biogenesis (GO:0042273) | 2.74225937 |
| 90 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.73470074 |
| 91 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.72798937 |
| 92 | mitotic nuclear envelope reassembly (GO:0007084) | 2.72228834 |
| 93 | nuclear envelope reassembly (GO:0031468) | 2.72228834 |
| 94 | triglyceride biosynthetic process (GO:0019432) | 2.71842789 |
| 95 | nuclear envelope disassembly (GO:0051081) | 2.71727777 |
| 96 | membrane disassembly (GO:0030397) | 2.71727777 |
| 97 | establishment of mitochondrion localization (GO:0051654) | 2.71178686 |
| 98 | mitotic recombination (GO:0006312) | 2.70550844 |
| 99 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.68928064 |
| 100 | substantia nigra development (GO:0021762) | 2.67750463 |
| 101 | nucleobase catabolic process (GO:0046113) | 2.67422880 |
| 102 | folic acid metabolic process (GO:0046655) | 2.67059262 |
| 103 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.66812981 |
| 104 | NADPH regeneration (GO:0006740) | 2.66640248 |
| 105 | DNA geometric change (GO:0032392) | 2.64252237 |
| 106 | viral transcription (GO:0019083) | 2.64202849 |
| 107 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.64072846 |
| 108 | neutral lipid biosynthetic process (GO:0046460) | 2.63619404 |
| 109 | acylglycerol biosynthetic process (GO:0046463) | 2.63619404 |
| 110 | glyoxylate metabolic process (GO:0046487) | 2.63218485 |
| 111 | carnitine metabolic process (GO:0009437) | 2.61701741 |
| 112 | mitochondrial fusion (GO:0008053) | 2.60371002 |
| 113 | glucose catabolic process (GO:0006007) | 2.60323909 |
| 114 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.59217239 |
| 115 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.59000103 |
| 116 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.58799267 |
| 117 | plasma lipoprotein particle clearance (GO:0034381) | 2.58381553 |
| 118 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.58202861 |
| 119 | protein localization to chromosome, centromeric region (GO:0071459) | 2.57963458 |
| 120 | positive regulation of B cell differentiation (GO:0045579) | 2.57747262 |
| 121 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.57514015 |
| 122 | ethanol oxidation (GO:0006069) | 2.56983379 |
| 123 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.56747864 |
| 124 | UV protection (GO:0009650) | 2.56001209 |
| 125 | mitotic sister chromatid segregation (GO:0000070) | 2.55339781 |
| 126 | aromatic amino acid family catabolic process (GO:0009074) | 2.55282431 |
| 127 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.55142580 |
| 128 | isoprenoid biosynthetic process (GO:0008299) | 2.54765444 |
| 129 | aspartate family amino acid catabolic process (GO:0009068) | 2.54293459 |
| 130 | copper ion homeostasis (GO:0055070) | 2.53938952 |
| 131 | translational termination (GO:0006415) | 2.53156777 |
| 132 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.51020659 |
| 133 | acidic amino acid transport (GO:0015800) | 2.50997682 |
| 134 | nuclear envelope organization (GO:0006998) | 2.50238392 |
| 135 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.49994236 |
| 136 | cholesterol metabolic process (GO:0008203) | 2.49989998 |
| 137 | acyl-CoA metabolic process (GO:0006637) | 2.49911535 |
| 138 | thioester metabolic process (GO:0035383) | 2.49911535 |
| 139 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.49160344 |
| 140 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.48331172 |
| 141 | serine family amino acid metabolic process (GO:0009069) | 2.47468646 |
| 142 | serine transport (GO:0032329) | 2.46810870 |
| 143 | virion attachment to host cell (GO:0019062) | 2.45691474 |
| 144 | adhesion of symbiont to host cell (GO:0044650) | 2.45691474 |
| 145 | acetyl-CoA metabolic process (GO:0006084) | 2.45584986 |
| 146 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.45318008 |
| 147 | intestinal cholesterol absorption (GO:0030299) | 2.44474660 |
| 148 | translational initiation (GO:0006413) | 2.44386075 |
| 149 | translational elongation (GO:0006414) | 2.44135644 |
| 150 | purine nucleobase biosynthetic process (GO:0009113) | 2.43289375 |
| 151 | ethanol metabolic process (GO:0006067) | 2.42998028 |
| 152 | neurotransmitter uptake (GO:0001504) | 2.42510301 |
| 153 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.42445845 |
| 154 | establishment of viral latency (GO:0019043) | 2.41624369 |
| 155 | response to peptidoglycan (GO:0032494) | 2.41119903 |
| 156 | protein export from nucleus (GO:0006611) | 2.39765930 |
| 157 | cellular modified amino acid catabolic process (GO:0042219) | 2.39639363 |
| 158 | iron coordination entity transport (GO:1901678) | 2.39495189 |
| 159 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.39246065 |
| 160 | response to food (GO:0032094) | 2.38276146 |
| 161 | L-glutamate transport (GO:0015813) | 2.37733100 |
| 162 | response to methylmercury (GO:0051597) | 2.37670525 |
| 163 | dicarboxylic acid catabolic process (GO:0043649) | 2.37457375 |
| 164 | triglyceride homeostasis (GO:0070328) | 2.37022480 |
| 165 | acylglycerol homeostasis (GO:0055090) | 2.37022480 |
| 166 | apical protein localization (GO:0045176) | 2.36757490 |
| 167 | DNA conformation change (GO:0071103) | 2.36710110 |
| 168 | ceramide biosynthetic process (GO:0046513) | 2.36686241 |
| 169 | response to pheromone (GO:0019236) | 2.36629753 |
| 170 | NADH metabolic process (GO:0006734) | 2.36164135 |
| 171 | mitochondrial DNA metabolic process (GO:0032042) | 2.35951959 |
| 172 | bile acid biosynthetic process (GO:0006699) | 2.35467744 |
| 173 | protein targeting to ER (GO:0045047) | 2.35458033 |
| 174 | protein localization to endosome (GO:0036010) | 2.35239349 |
| 175 | nucleobase biosynthetic process (GO:0046112) | 2.35213262 |
| 176 | protein complex localization (GO:0031503) | 2.34636616 |
| 177 | rRNA transcription (GO:0009303) | 2.34635025 |
| 178 | protein retention in ER lumen (GO:0006621) | 2.34466623 |
| 179 | cotranslational protein targeting to membrane (GO:0006613) | 2.33259658 |
| 180 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.32938606 |
| 181 | regulation of superoxide anion generation (GO:0032928) | 2.32510086 |
| 182 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.32500522 |
| 183 | viral mRNA export from host cell nucleus (GO:0046784) | 2.32352195 |
| 184 | cellular protein complex localization (GO:0034629) | 2.31436877 |
| 185 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.30862417 |
| 186 | sister chromatid segregation (GO:0000819) | 2.30643203 |
| 187 | ADP metabolic process (GO:0046031) | 2.30274823 |
| 188 | tricarboxylic acid cycle (GO:0006099) | 2.28836424 |
| 189 | IMP biosynthetic process (GO:0006188) | 2.27065740 |
| 190 | protein localization to endoplasmic reticulum (GO:0070972) | 2.26919600 |
| 191 | hyaluronan catabolic process (GO:0030214) | 2.26298074 |
| 192 | negative regulation of necroptotic process (GO:0060546) | 2.25478393 |
| 193 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.22580422 |
| 194 | peptidyl-arginine N-methylation (GO:0035246) | 2.22436411 |
| 195 | peptidyl-arginine methylation (GO:0018216) | 2.22436411 |
| 196 | tRNA aminoacylation for protein translation (GO:0006418) | 2.22398506 |
| 197 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.22303877 |
| 198 | mRNA stabilization (GO:0048255) | 2.21017098 |
| 199 | RNA stabilization (GO:0043489) | 2.21017098 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.48872316 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.43945907 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.91272084 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.66658424 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.55505261 |
| 6 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.31299667 |
| 7 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.88911519 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.88091946 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.88042504 |
| 10 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.80050898 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 2.77666607 |
| 12 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.75613280 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.67125016 |
| 14 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.51244191 |
| 15 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.49038900 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.40360099 |
| 17 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.39741958 |
| 18 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.28304349 |
| 19 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.24078493 |
| 20 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.18530348 |
| 21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.18083604 |
| 22 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.16870910 |
| 23 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.16839049 |
| 24 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.14130051 |
| 25 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.08981522 |
| 26 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.05006288 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.99804801 |
| 28 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.98969630 |
| 29 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.97385324 |
| 30 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.96953555 |
| 31 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.94591826 |
| 32 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.93701453 |
| 33 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.89203765 |
| 34 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.88130150 |
| 35 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.84005175 |
| 36 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.83253591 |
| 37 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.82012416 |
| 38 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.80735481 |
| 39 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.80554677 |
| 40 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77813817 |
| 41 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.76712765 |
| 42 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.74945835 |
| 43 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.74118955 |
| 44 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.72850637 |
| 45 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.69851997 |
| 46 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.67282531 |
| 47 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.63536942 |
| 48 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.62010572 |
| 49 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.61543275 |
| 50 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.61433654 |
| 51 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.54730134 |
| 52 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.54419748 |
| 53 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.54048601 |
| 54 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.53660265 |
| 55 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.52401178 |
| 56 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.51802601 |
| 57 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.50794255 |
| 58 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.50300147 |
| 59 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.49819638 |
| 60 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.49521613 |
| 61 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48989199 |
| 62 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.48740099 |
| 63 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.48634425 |
| 64 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.48271456 |
| 65 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.47935112 |
| 66 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.46278508 |
| 67 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.46140918 |
| 68 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.45211415 |
| 69 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.44205984 |
| 70 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.43234150 |
| 71 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.42877098 |
| 72 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.42256577 |
| 73 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41995301 |
| 74 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.41426090 |
| 75 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.39117307 |
| 76 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.38762020 |
| 77 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.38170495 |
| 78 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.37333720 |
| 79 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.37332908 |
| 80 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.36194224 |
| 81 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.35850493 |
| 82 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.35631496 |
| 83 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.35507704 |
| 84 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.34976547 |
| 85 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.33780750 |
| 86 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.32793355 |
| 87 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.32470739 |
| 88 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32283887 |
| 89 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.32276527 |
| 90 | MAF_26560356_Chip-Seq_TH1_Human | 1.32169320 |
| 91 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.31745265 |
| 92 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.30630460 |
| 93 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.30589833 |
| 94 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.30507519 |
| 95 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.27673111 |
| 96 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.27673111 |
| 97 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.25545234 |
| 98 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.25399749 |
| 99 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.25202672 |
| 100 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.24450317 |
| 101 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.24358585 |
| 102 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.23018043 |
| 103 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.21430986 |
| 104 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.20586416 |
| 105 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.20425858 |
| 106 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.20317362 |
| 107 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18591462 |
| 108 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.18228011 |
| 109 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.17889381 |
| 110 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.16558524 |
| 111 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.16236487 |
| 112 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.16193000 |
| 113 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.16097137 |
| 114 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.16039148 |
| 115 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.15803113 |
| 116 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.15669086 |
| 117 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.15525068 |
| 118 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.15525068 |
| 119 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.15431847 |
| 120 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.14940216 |
| 121 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.14733199 |
| 122 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.14599609 |
| 123 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.13880604 |
| 124 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.13202607 |
| 125 | UTX_26944678_Chip-Seq_JUKART_Human | 1.13021278 |
| 126 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.11519742 |
| 127 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.11496938 |
| 128 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.11433915 |
| 129 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.11334828 |
| 130 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.10275230 |
| 131 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10198829 |
| 132 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10113454 |
| 133 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.09984725 |
| 134 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.09894819 |
| 135 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.08493568 |
| 136 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.08201958 |
| 137 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.07902785 |
| 138 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.07364721 |
| 139 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.07276070 |
| 140 | MAF_26560356_Chip-Seq_TH2_Human | 1.07123935 |
| 141 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.05833585 |
| 142 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.04171191 |
| 143 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.03670819 |
| 144 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03647867 |
| 145 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.03616369 |
| 146 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.03497750 |
| 147 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02795879 |
| 148 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.02775640 |
| 149 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.02307468 |
| 150 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.01911227 |
| 151 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.01451031 |
| 152 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.01170277 |
| 153 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01063168 |
| 154 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01052205 |
| 155 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.99857680 |
| 156 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.99795991 |
| 157 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.99437924 |
| 158 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98888273 |
| 159 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.97955555 |
| 160 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.97608579 |
| 161 | NCOR_22424771_ChIP-Seq_293T_Human | 0.97079677 |
| 162 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.96505181 |
| 163 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.94588059 |
| 164 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.94066937 |
| 165 | GATA1_22025678_ChIP-Seq_K562_Human | 0.93169779 |
| 166 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.91562922 |
| 167 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.91349577 |
| 168 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.91160436 |
| 169 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.89861596 |
| 170 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.89427029 |
| 171 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.88904831 |
| 172 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88143785 |
| 173 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.87359160 |
| 174 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.85990963 |
| 175 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85725855 |
| 176 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.84964947 |
| 177 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.84796884 |
| 178 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.84674449 |
| 179 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.83541485 |
| 180 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.83540519 |
| 181 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83424569 |
| 182 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.83402680 |
| 183 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.81541052 |
| 184 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.77744185 |
| 185 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.76167244 |
| 186 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.75341778 |
| 187 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.74728590 |
| 188 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.74482053 |
| 189 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.73737149 |
| 190 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.72458203 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.92049835 |
| 2 | MP0003329_amyloid_beta_deposits | 5.44969376 |
| 3 | MP0009840_abnormal_foam_cell | 4.34896843 |
| 4 | MP0000604_amyloidosis | 3.60157322 |
| 5 | MP0002877_abnormal_melanocyte_morpholog | 3.58244809 |
| 6 | MP0005360_urolithiasis | 3.36134604 |
| 7 | MP0005365_abnormal_bile_salt | 3.06987689 |
| 8 | MP0003191_abnormal_cellular_cholesterol | 3.02861652 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.94084753 |
| 10 | MP0003111_abnormal_nucleus_morphology | 2.84117513 |
| 11 | MP0000920_abnormal_myelination | 2.74634055 |
| 12 | MP0010094_abnormal_chromosome_stability | 2.73909239 |
| 13 | MP0002396_abnormal_hematopoietic_system | 2.70918704 |
| 14 | MP0003693_abnormal_embryo_hatching | 2.68012961 |
| 15 | MP0003690_abnormal_glial_cell | 2.50029925 |
| 16 | MP0003880_abnormal_central_pattern | 2.41766004 |
| 17 | MP0008875_abnormal_xenobiotic_pharmacok | 2.39607423 |
| 18 | MP0004957_abnormal_blastocyst_morpholog | 2.38444510 |
| 19 | MP0003077_abnormal_cell_cycle | 2.28991267 |
| 20 | MP0004270_analgesia | 2.25763572 |
| 21 | MP0008057_abnormal_DNA_replication | 2.15383637 |
| 22 | MP0003763_abnormal_thymus_physiology | 2.14345294 |
| 23 | MP0005085_abnormal_gallbladder_physiolo | 2.12826128 |
| 24 | MP0004233_abnormal_muscle_weight | 2.01995154 |
| 25 | MP0003705_abnormal_hypodermis_morpholog | 1.98033985 |
| 26 | MP0008007_abnormal_cellular_replicative | 1.96557771 |
| 27 | MP0003566_abnormal_cell_adhesion | 1.93393815 |
| 28 | MP0005332_abnormal_amino_acid | 1.89499798 |
| 29 | MP0004808_abnormal_hematopoietic_stem | 1.88013657 |
| 30 | MP0001666_abnormal_nutrient_absorption | 1.86148002 |
| 31 | MP0010329_abnormal_lipoprotein_level | 1.81773967 |
| 32 | MP0001835_abnormal_antigen_presentation | 1.80549047 |
| 33 | MP0005058_abnormal_lysosome_morphology | 1.79471371 |
| 34 | MP0008932_abnormal_embryonic_tissue | 1.74552557 |
| 35 | MP0003634_abnormal_glial_cell | 1.73040735 |
| 36 | MP0009384_cardiac_valve_regurgitation | 1.69176060 |
| 37 | MP0000350_abnormal_cell_proliferation | 1.69123370 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.63596355 |
| 39 | MP0005464_abnormal_platelet_physiology | 1.60448823 |
| 40 | MP0010352_gastrointestinal_tract_polyps | 1.59671276 |
| 41 | MP0000747_muscle_weakness | 1.58516192 |
| 42 | MP0001730_embryonic_growth_arrest | 1.56832440 |
| 43 | MP0005076_abnormal_cell_differentiation | 1.55587086 |
| 44 | MP0010234_abnormal_vibrissa_follicle | 1.54973560 |
| 45 | MP0008058_abnormal_DNA_repair | 1.54740905 |
| 46 | MP0001853_heart_inflammation | 1.52612123 |
| 47 | MP0003436_decreased_susceptibility_to | 1.52157748 |
| 48 | MP0003632_abnormal_nervous_system | 1.50778755 |
| 49 | MP0002009_preneoplasia | 1.50644386 |
| 50 | MP0002166_altered_tumor_susceptibility | 1.49998100 |
| 51 | MP0008438_abnormal_cutaneous_collagen | 1.48278616 |
| 52 | MP0000490_abnormal_crypts_of | 1.46880862 |
| 53 | MP0003195_calcinosis | 1.46313572 |
| 54 | MP0003635_abnormal_synaptic_transmissio | 1.45159368 |
| 55 | MP0002398_abnormal_bone_marrow | 1.44528450 |
| 56 | MP0001440_abnormal_grooming_behavior | 1.44215387 |
| 57 | MP0001529_abnormal_vocalization | 1.43860534 |
| 58 | MP0000858_altered_metastatic_potential | 1.43567795 |
| 59 | MP0002064_seizures | 1.43238055 |
| 60 | MP0005423_abnormal_somatic_nervous | 1.40620759 |
| 61 | MP0005083_abnormal_biliary_tract | 1.39710897 |
| 62 | MP0004859_abnormal_synaptic_plasticity | 1.39344242 |
| 63 | MP0003221_abnormal_cardiomyocyte_apopto | 1.36662959 |
| 64 | MP0000313_abnormal_cell_death | 1.36246942 |
| 65 | MP0002090_abnormal_vision | 1.35072705 |
| 66 | MP0008260_abnormal_autophagy | 1.34241383 |
| 67 | MP0000703_abnormal_thymus_morphology | 1.33413952 |
| 68 | MP0003786_premature_aging | 1.32506006 |
| 69 | MP0005501_abnormal_skin_physiology | 1.31624546 |
| 70 | MP0003300_gastrointestinal_ulcer | 1.31526205 |
| 71 | MP0009278_abnormal_bone_marrow | 1.29232040 |
| 72 | MP0006035_abnormal_mitochondrial_morpho | 1.28888838 |
| 73 | MP0002796_impaired_skin_barrier | 1.28508850 |
| 74 | MP0004858_abnormal_nervous_system | 1.27382442 |
| 75 | MP0005621_abnormal_cell_physiology | 1.26874306 |
| 76 | MP0002019_abnormal_tumor_incidence | 1.26686243 |
| 77 | * MP0002118_abnormal_lipid_homeostasis | 1.25949519 |
| 78 | MP0005408_hypopigmentation | 1.25835999 |
| 79 | MP0002722_abnormal_immune_system | 1.25272221 |
| 80 | MP0000778_abnormal_nervous_system | 1.24998159 |
| 81 | MP0001661_extended_life_span | 1.24765095 |
| 82 | * MP0002080_prenatal_lethality | 1.24585305 |
| 83 | MP0005451_abnormal_body_composition | 1.23512404 |
| 84 | MP0000358_abnormal_cell_content/ | 1.22522893 |
| 85 | MP0002006_tumorigenesis | 1.20540664 |
| 86 | MP0002060_abnormal_skin_morphology | 1.19849415 |
| 87 | MP0002429_abnormal_blood_cell | 1.18786946 |
| 88 | MP0004947_skin_inflammation | 1.17592756 |
| 89 | MP0000465_gastrointestinal_hemorrhage | 1.17282176 |
| 90 | MP0002420_abnormal_adaptive_immunity | 1.14334712 |
| 91 | MP0005000_abnormal_immune_tolerance | 1.13948198 |
| 92 | MP0006276_abnormal_autonomic_nervous | 1.13776084 |
| 93 | MP0000685_abnormal_immune_system | 1.13592214 |
| 94 | MP0001819_abnormal_immune_cell | 1.12646305 |
| 95 | MP0003950_abnormal_plasma_membrane | 1.12562487 |
| 96 | MP0003984_embryonic_growth_retardation | 1.12300689 |
| 97 | MP0002419_abnormal_innate_immunity | 1.11308292 |
| 98 | MP0001672_abnormal_embryogenesis/_devel | 1.10845164 |
| 99 | MP0005380_embryogenesis_phenotype | 1.10845164 |
| 100 | MP0000689_abnormal_spleen_morphology | 1.10780172 |
| 101 | MP0000716_abnormal_immune_system | 1.10291301 |
| 102 | MP0010307_abnormal_tumor_latency | 1.09981169 |
| 103 | MP0005384_cellular_phenotype | 1.09352301 |
| 104 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.06873140 |
| 105 | MP0005397_hematopoietic_system_phenotyp | 1.06423252 |
| 106 | MP0001545_abnormal_hematopoietic_system | 1.06423252 |
| 107 | MP0002452_abnormal_antigen_presenting | 1.06098805 |
| 108 | MP0001849_ear_inflammation | 1.05829510 |
| 109 | MP0003631_nervous_system_phenotype | 1.04808159 |
| 110 | MP0000372_irregular_coat_pigmentation | 1.04602990 |
| 111 | MP0005330_cardiomyopathy | 1.04467364 |
| 112 | MP0003303_peritoneal_inflammation | 1.04417004 |
| 113 | MP0002088_abnormal_embryonic_growth/wei | 1.04119898 |
| 114 | MP0003091_abnormal_cell_migration | 1.03609697 |
| 115 | MP0003453_abnormal_keratinocyte_physiol | 1.02434428 |
| 116 | MP0002272_abnormal_nervous_system | 1.02393759 |
| 117 | MP0002229_neurodegeneration | 1.01526121 |
| 118 | MP0004885_abnormal_endolymph | 1.01071492 |
| 119 | MP0001697_abnormal_embryo_size | 1.00706621 |
| 120 | MP0000013_abnormal_adipose_tissue | 1.00595956 |
| 121 | MP0001800_abnormal_humoral_immune | 0.99222398 |
| 122 | MP0009697_abnormal_copulation | 0.98482969 |
| 123 | MP0001216_abnormal_epidermal_layer | 0.97526367 |
| 124 | MP0003172_abnormal_lysosome_physiology | 0.97257475 |
| 125 | MP0000647_abnormal_sebaceous_gland | 0.96052811 |
| 126 | MP0002723_abnormal_immune_serum | 0.95769139 |
| 127 | MP0003828_pulmonary_edema | 0.94894058 |
| 128 | MP0002063_abnormal_learning/memory/cond | 0.94499433 |
| 129 | MP0005025_abnormal_response_to | 0.94227811 |
| 130 | MP0002086_abnormal_extraembryonic_tissu | 0.93611465 |
| 131 | MP0001542_abnormal_bone_strength | 0.93529924 |
| 132 | MP0002148_abnormal_hypersensitivity_rea | 0.93393273 |
| 133 | MP0004381_abnormal_hair_follicle | 0.91780990 |
| 134 | MP0000609_abnormal_liver_physiology | 0.91625514 |
| 135 | MP0000462_abnormal_digestive_system | 0.91421878 |
| 136 | MP0001486_abnormal_startle_reflex | 0.89917626 |
| 137 | MP0009046_muscle_twitch | 0.89492641 |
| 138 | MP0002734_abnormal_mechanical_nocicepti | 0.89393122 |
| 139 | MP0009745_abnormal_behavioral_response | 0.89226145 |
| 140 | MP0001905_abnormal_dopamine_level | 0.88332249 |
| 141 | MP0003136_yellow_coat_color | 0.87944525 |
| 142 | MP0000003_abnormal_adipose_tissue | 0.87923905 |
| 143 | MP0003633_abnormal_nervous_system | 0.87841042 |
| 144 | MP0005165_increased_susceptibility_to | 0.87568131 |
| 145 | MP0003718_maternal_effect | 0.86169550 |
| 146 | MP0009931_abnormal_skin_appearance | 0.85572680 |
| 147 | MP0004742_abnormal_vestibular_system | 0.85184958 |
| 148 | MP0001756_abnormal_urination | 0.83887250 |
| 149 | MP0003868_abnormal_feces_composition | 0.83355455 |
| 150 | MP0002295_abnormal_pulmonary_circulatio | 0.81480810 |
| 151 | MP0010678_abnormal_skin_adnexa | 0.80825312 |
| 152 | MP0010630_abnormal_cardiac_muscle | 0.80813653 |
| 153 | MP0005410_abnormal_fertilization | 0.80169205 |
| 154 | MP0001873_stomach_inflammation | 0.80074388 |
| 155 | MP0003448_altered_tumor_morphology | 0.79476133 |
| 156 | MP0005257_abnormal_intraocular_pressure | 0.79369460 |
| 157 | MP0002066_abnormal_motor_capabilities/c | 0.78906678 |
| 158 | MP0004185_abnormal_adipocyte_glucose | 0.78560084 |
| 159 | MP0001915_intracranial_hemorrhage | 0.77535329 |
| 160 | MP0005386_behavior/neurological_phenoty | 0.76622369 |
| 161 | MP0004924_abnormal_behavior | 0.76622369 |
| 162 | MP0005319_abnormal_enzyme/_coenzyme | 0.75955485 |
| 163 | MP0002733_abnormal_thermal_nociception | 0.75891807 |
| 164 | MP0002909_abnormal_adrenal_gland | 0.75616467 |
| 165 | MP0003656_abnormal_erythrocyte_physiolo | 0.75602932 |
| 166 | MP0004043_abnormal_pH_regulation | 0.75582397 |
| 167 | MP0005275_abnormal_skin_tensile | 0.73788840 |
| 168 | MP0002572_abnormal_emotion/affect_behav | 0.73033353 |
| 169 | MP0001299_abnormal_eye_distance/ | 0.72997573 |
| 170 | MP0004019_abnormal_vitamin_homeostasis | 0.72824990 |
| 171 | MP0001727_abnormal_embryo_implantation | 0.72465078 |
| 172 | MP0004130_abnormal_muscle_cell | 0.72281292 |
| 173 | MP0002067_abnormal_sensory_capabilities | 0.72279086 |
| 174 | MP0002184_abnormal_innervation | 0.72176639 |
| 175 | MP0000751_myopathy | 0.71440065 |
| 176 | MP0004272_abnormal_basement_membrane | 0.70986130 |
| 177 | MP0001984_abnormal_olfaction | 0.69689113 |
| 178 | MP0005636_abnormal_mineral_homeostasis | 0.67903766 |
| 179 | MP0000955_abnormal_spinal_cord | 0.66710189 |
| 180 | MP0009643_abnormal_urine_homeostasis | 0.66688008 |
| 181 | MP0009780_abnormal_chondrocyte_physiolo | 0.66261762 |
| 182 | MP0003183_abnormal_peptide_metabolism | 0.63323954 |
| 183 | MP0001177_atelectasis | 0.62550234 |
| 184 | MP0002882_abnormal_neuron_morphology | 0.61713118 |
| 185 | MP0008569_lethality_at_weaning | 0.54957082 |
| 186 | MP0002152_abnormal_brain_morphology | 0.54902175 |
| 187 | MP0006036_abnormal_mitochondrial_physio | 0.54739669 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Neurofibrillary tangles (HP:0002185) | 5.26732075 |
| 2 | Parakeratosis (HP:0001036) | 4.30943660 |
| 3 | Hyperlipoproteinemia (HP:0010980) | 4.28458210 |
| 4 | Cerebral inclusion bodies (HP:0100314) | 4.15970699 |
| 5 | Xanthomatosis (HP:0000991) | 3.82488270 |
| 6 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.56015450 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 3.11684899 |
| 8 | Supranuclear gaze palsy (HP:0000605) | 3.10891588 |
| 9 | Hyperglycinemia (HP:0002154) | 3.08941161 |
| 10 | Increased serum pyruvate (HP:0003542) | 3.06806861 |
| 11 | Abnormality of glycolysis (HP:0004366) | 3.06806861 |
| 12 | Aplasia involving bones of the upper limbs (HP:0009823) | 3.06616166 |
| 13 | Aplasia of the phalanges of the hand (HP:0009802) | 3.06616166 |
| 14 | Aplasia involving bones of the extremities (HP:0009825) | 3.06616166 |
| 15 | Ragged-red muscle fibers (HP:0003200) | 3.04625728 |
| 16 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.03973959 |
| 17 | Abnormality of glycine metabolism (HP:0010895) | 3.02937084 |
| 18 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.02937084 |
| 19 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.02431515 |
| 20 | Vertebral compression fractures (HP:0002953) | 2.99255985 |
| 21 | Intrahepatic cholestasis (HP:0001406) | 2.89644254 |
| 22 | Amniotic constriction ring (HP:0009775) | 2.86902729 |
| 23 | Abnormality of placental membranes (HP:0011409) | 2.86902729 |
| 24 | Hypolipoproteinemia (HP:0010981) | 2.81942966 |
| 25 | Hyperacusis (HP:0010780) | 2.79722701 |
| 26 | Selective tooth agenesis (HP:0001592) | 2.78238766 |
| 27 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.75487549 |
| 28 | Thrombocytosis (HP:0001894) | 2.74338277 |
| 29 | Progressive muscle weakness (HP:0003323) | 2.67027360 |
| 30 | Hypoalphalipoproteinemia (HP:0003233) | 2.66807228 |
| 31 | Hyperglycinuria (HP:0003108) | 2.63670269 |
| 32 | Premature rupture of membranes (HP:0001788) | 2.61110757 |
| 33 | Megalencephaly (HP:0001355) | 2.60281713 |
| 34 | Deep venous thrombosis (HP:0002625) | 2.59424227 |
| 35 | Akinesia (HP:0002304) | 2.59108599 |
| 36 | Microvesicular hepatic steatosis (HP:0001414) | 2.58599440 |
| 37 | Recurrent viral infections (HP:0004429) | 2.56315471 |
| 38 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.53946292 |
| 39 | Abnormal pupillary function (HP:0007686) | 2.52089245 |
| 40 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.45147581 |
| 41 | Osteolytic defects of the hand bones (HP:0009699) | 2.45147581 |
| 42 | Fatigue (HP:0012378) | 2.44852174 |
| 43 | Hypokalemic alkalosis (HP:0001949) | 2.41930448 |
| 44 | Spastic paraparesis (HP:0002313) | 2.40923397 |
| 45 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.40723199 |
| 46 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.40723199 |
| 47 | Autoamputation (HP:0001218) | 2.39270686 |
| 48 | Pheochromocytoma (HP:0002666) | 2.38204846 |
| 49 | Abnormality of the Achilles tendon (HP:0005109) | 2.33039951 |
| 50 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.32461760 |
| 51 | Cerebral hemorrhage (HP:0001342) | 2.29930574 |
| 52 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.29593816 |
| 53 | Abnormality of oral frenula (HP:0000190) | 2.29459250 |
| 54 | Neuroendocrine neoplasm (HP:0100634) | 2.27495765 |
| 55 | Ketosis (HP:0001946) | 2.24679442 |
| 56 | Trismus (HP:0000211) | 2.24448244 |
| 57 | Achilles tendon contracture (HP:0001771) | 2.22863975 |
| 58 | Abnormality of the corticospinal tract (HP:0002492) | 2.19957040 |
| 59 | Hyperammonemia (HP:0001987) | 2.19164387 |
| 60 | Insomnia (HP:0100785) | 2.18831031 |
| 61 | Ileus (HP:0002595) | 2.17968854 |
| 62 | Abnormal gallbladder physiology (HP:0012438) | 2.17842719 |
| 63 | Cholecystitis (HP:0001082) | 2.17842719 |
| 64 | Fat malabsorption (HP:0002630) | 2.16127414 |
| 65 | Paraparesis (HP:0002385) | 2.15026791 |
| 66 | Insidious onset (HP:0003587) | 2.14685969 |
| 67 | Termporal pattern (HP:0011008) | 2.14685969 |
| 68 | Rough bone trabeculation (HP:0100670) | 2.14269721 |
| 69 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.14006780 |
| 70 | Multiple enchondromatosis (HP:0005701) | 2.13716039 |
| 71 | Abnormality of the thoracic spine (HP:0100711) | 2.12435909 |
| 72 | Upper motor neuron abnormality (HP:0002127) | 2.11081550 |
| 73 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.09811558 |
| 74 | Hemiplegia (HP:0002301) | 2.09168944 |
| 75 | Progressive external ophthalmoplegia (HP:0000590) | 2.08988116 |
| 76 | Impaired platelet aggregation (HP:0003540) | 2.08413286 |
| 77 | Abnormal platelet function (HP:0011869) | 2.08413286 |
| 78 | Thoracic kyphosis (HP:0002942) | 2.08210899 |
| 79 | Cellulitis (HP:0100658) | 2.06967580 |
| 80 | Intention tremor (HP:0002080) | 2.06700849 |
| 81 | Ankyloglossia (HP:0010296) | 2.02965598 |
| 82 | Abnormality of the umbilical cord (HP:0010881) | 2.02316578 |
| 83 | Cerebral hypomyelination (HP:0006808) | 2.01046539 |
| 84 | Truncal ataxia (HP:0002078) | 1.99559154 |
| 85 | Petechiae (HP:0000967) | 1.98986651 |
| 86 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.97924835 |
| 87 | Back pain (HP:0003418) | 1.97387839 |
| 88 | Gout (HP:0001997) | 1.96681112 |
| 89 | Clumsiness (HP:0002312) | 1.95612945 |
| 90 | Distal lower limb amyotrophy (HP:0008944) | 1.94787783 |
| 91 | Steatorrhea (HP:0002570) | 1.94290212 |
| 92 | Abnormality of glycolipid metabolism (HP:0010969) | 1.91939795 |
| 93 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.91939795 |
| 94 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.91939795 |
| 95 | Short nail (HP:0001799) | 1.91909572 |
| 96 | Cerebral edema (HP:0002181) | 1.89213637 |
| 97 | Hepatosplenomegaly (HP:0001433) | 1.88351312 |
| 98 | Increased connective tissue (HP:0009025) | 1.87996938 |
| 99 | Polyphagia (HP:0002591) | 1.87711605 |
| 100 | Brushfield spots (HP:0001088) | 1.86971968 |
| 101 | Syringomyelia (HP:0003396) | 1.86115249 |
| 102 | Spinal cord lesions (HP:0100561) | 1.86115249 |
| 103 | Distal lower limb muscle weakness (HP:0009053) | 1.86069476 |
| 104 | Athetosis (HP:0002305) | 1.85941888 |
| 105 | Orthostatic hypotension (HP:0001278) | 1.84842202 |
| 106 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.84727044 |
| 107 | Deviation of the thumb (HP:0009603) | 1.82683579 |
| 108 | Spastic gait (HP:0002064) | 1.82292763 |
| 109 | Ketoacidosis (HP:0001993) | 1.81109464 |
| 110 | Hyperphosphaturia (HP:0003109) | 1.79312586 |
| 111 | Flat acetabular roof (HP:0003180) | 1.79263169 |
| 112 | Irritability (HP:0000737) | 1.79192013 |
| 113 | Delusions (HP:0000746) | 1.78976540 |
| 114 | Mutism (HP:0002300) | 1.78973472 |
| 115 | Peripheral hypomyelination (HP:0007182) | 1.78907678 |
| 116 | Abnormality of serum amino acid levels (HP:0003112) | 1.78492711 |
| 117 | Increased cerebral lipofuscin (HP:0011813) | 1.77367469 |
| 118 | Lethargy (HP:0001254) | 1.77361113 |
| 119 | Postnatal microcephaly (HP:0005484) | 1.77182773 |
| 120 | Colitis (HP:0002583) | 1.76979120 |
| 121 | Granulocytopenia (HP:0001913) | 1.75830724 |
| 122 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.75226966 |
| 123 | Ankle clonus (HP:0011448) | 1.75043135 |
| 124 | Generalized myoclonic seizures (HP:0002123) | 1.74974049 |
| 125 | IgA deficiency (HP:0002720) | 1.74281719 |
| 126 | Brittle hair (HP:0002299) | 1.73490256 |
| 127 | Loss of speech (HP:0002371) | 1.73320580 |
| 128 | Gastrointestinal inflammation (HP:0004386) | 1.72904961 |
| 129 | Hemiparesis (HP:0001269) | 1.71939020 |
| 130 | Reticulocytosis (HP:0001923) | 1.71655857 |
| 131 | Agammaglobulinemia (HP:0004432) | 1.70509375 |
| 132 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.70353240 |
| 133 | Restlessness (HP:0000711) | 1.70000507 |
| 134 | Poor suck (HP:0002033) | 1.69879404 |
| 135 | Testicular atrophy (HP:0000029) | 1.69839980 |
| 136 | CNS demyelination (HP:0007305) | 1.69816215 |
| 137 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.69735998 |
| 138 | Diminished movement (HP:0002374) | 1.69575807 |
| 139 | Nonimmune hydrops fetalis (HP:0001790) | 1.69109830 |
| 140 | Sensory axonal neuropathy (HP:0003390) | 1.68997757 |
| 141 | Increased serum ferritin (HP:0003281) | 1.68980178 |
| 142 | Delayed CNS myelination (HP:0002188) | 1.68723378 |
| 143 | Dysostosis multiplex (HP:0000943) | 1.68065254 |
| 144 | B lymphocytopenia (HP:0010976) | 1.67534092 |
| 145 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.67469116 |
| 146 | Dialeptic seizures (HP:0011146) | 1.66873019 |
| 147 | Abnormality of methionine metabolism (HP:0010901) | 1.65968211 |
| 148 | Abnormality of reticulocytes (HP:0004312) | 1.65142536 |
| 149 | Abnormal eating behavior (HP:0100738) | 1.64832965 |
| 150 | Ridged nail (HP:0001807) | 1.64588276 |
| 151 | Neuronal loss in central nervous system (HP:0002529) | 1.64284504 |
| 152 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.64261176 |
| 153 | Chromsome breakage (HP:0040012) | 1.63546874 |
| 154 | Methylmalonic aciduria (HP:0012120) | 1.62700036 |
| 155 | Proximal placement of thumb (HP:0009623) | 1.62190714 |
| 156 | Epiphyseal stippling (HP:0010655) | 1.61311744 |
| 157 | Aplastic anemia (HP:0001915) | 1.61216489 |
| 158 | Hypoplastic left heart (HP:0004383) | 1.61058355 |
| 159 | Onion bulb formation (HP:0003383) | 1.60597479 |
| 160 | Alkalosis (HP:0001948) | 1.60336941 |
| 161 | Reduced antithrombin III activity (HP:0001976) | 1.60060462 |
| 162 | Abnormality of carpal bone ossification (HP:0006257) | 1.59284767 |
| 163 | Complement deficiency (HP:0004431) | 1.58709667 |
| 164 | Patellar dislocation (HP:0002999) | 1.58142847 |
| 165 | Progressive hearing impairment (HP:0001730) | 1.58112535 |
| 166 | Recurrent abscess formation (HP:0002722) | 1.58065333 |
| 167 | Pelvic girdle muscle weakness (HP:0003749) | 1.57518009 |
| 168 | Autoimmune hemolytic anemia (HP:0001890) | 1.57094584 |
| 169 | Abnormality of the tricuspid valve (HP:0001702) | 1.56312534 |
| 170 | Entropion (HP:0000621) | 1.55031521 |
| 171 | Viral hepatitis (HP:0006562) | 1.54900012 |
| 172 | Asymmetry of the thorax (HP:0001555) | 1.54170401 |
| 173 | Microretrognathia (HP:0000308) | 1.53193615 |
| 174 | Generalized amyotrophy (HP:0003700) | 1.52863250 |
| 175 | Abnormal trabecular bone morphology (HP:0100671) | 1.51987663 |
| 176 | Onycholysis (HP:0001806) | 1.51778867 |
| 177 | Long palpebral fissure (HP:0000637) | 1.51569025 |
| 178 | Reticulocytopenia (HP:0001896) | 1.51392190 |
| 179 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.51365517 |
| 180 | Ankle contracture (HP:0006466) | 1.50386239 |
| 181 | Hypergonadotropic hypogonadism (HP:0000815) | 1.50176070 |
| 182 | Abnormality of macrophages (HP:0004311) | 1.50130872 |
| 183 | Squamous cell carcinoma (HP:0002860) | 1.49566032 |
| 184 | Broad face (HP:0000283) | 1.48987214 |
| 185 | Hypokinesia (HP:0002375) | 1.48481535 |
| 186 | Abnormality of T cell physiology (HP:0011840) | 1.48245645 |
| 187 | Combined immunodeficiency (HP:0005387) | 1.48234805 |
| 188 | Acute lymphatic leukemia (HP:0006721) | 1.47927725 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 4.21077857 |
| 2 | STK39 | 3.85163462 |
| 3 | IRAK3 | 3.22309074 |
| 4 | MARK1 | 2.85743927 |
| 5 | ARAF | 2.58575155 |
| 6 | PRPF4B | 2.51262553 |
| 7 | LIMK1 | 2.46579290 |
| 8 | MUSK | 2.46577737 |
| 9 | OXSR1 | 2.46178675 |
| 10 | SMG1 | 2.43727729 |
| 11 | CDK12 | 2.37307078 |
| 12 | EEF2K | 2.27062916 |
| 13 | ERN1 | 2.26053362 |
| 14 | TESK2 | 2.16044188 |
| 15 | BCR | 2.15042703 |
| 16 | BCKDK | 1.92475620 |
| 17 | MAP3K9 | 1.88467183 |
| 18 | NTRK1 | 1.87660730 |
| 19 | MET | 1.87265762 |
| 20 | LMTK2 | 1.83792294 |
| 21 | FGFR2 | 1.79492720 |
| 22 | TTN | 1.78474204 |
| 23 | ICK | 1.77068664 |
| 24 | PAK6 | 1.76011949 |
| 25 | WNK4 | 1.73544428 |
| 26 | FER | 1.73233405 |
| 27 | PAK3 | 1.71179860 |
| 28 | EPHA4 | 1.70972603 |
| 29 | MST4 | 1.70521513 |
| 30 | NEK1 | 1.67400169 |
| 31 | EPHB1 | 1.66606952 |
| 32 | MAP3K11 | 1.58147347 |
| 33 | PHKG1 | 1.57015145 |
| 34 | PHKG2 | 1.57015145 |
| 35 | SCYL2 | 1.56605158 |
| 36 | KSR2 | 1.53130267 |
| 37 | ACVR1B | 1.52470808 |
| 38 | MAP2K3 | 1.51342302 |
| 39 | CDC7 | 1.48407271 |
| 40 | SRPK1 | 1.46409110 |
| 41 | NTRK2 | 1.37200950 |
| 42 | MAP3K14 | 1.37065205 |
| 43 | CDK8 | 1.32894713 |
| 44 | MAP4K1 | 1.26816405 |
| 45 | PBK | 1.26772240 |
| 46 | CSNK1G3 | 1.25830641 |
| 47 | MINK1 | 1.25545768 |
| 48 | DYRK2 | 1.22308946 |
| 49 | RPS6KB2 | 1.22281919 |
| 50 | MAP3K2 | 1.22236412 |
| 51 | PAK4 | 1.20912109 |
| 52 | MAP3K10 | 1.19508943 |
| 53 | MAP3K8 | 1.19142953 |
| 54 | RPS6KA4 | 1.18394702 |
| 55 | CDK4 | 1.17906987 |
| 56 | CDK6 | 1.16518124 |
| 57 | CSNK1G2 | 1.16030210 |
| 58 | TTK | 1.15976252 |
| 59 | TYRO3 | 1.14976519 |
| 60 | CDK14 | 1.14704400 |
| 61 | ROCK2 | 1.12794952 |
| 62 | EPHA2 | 1.12413350 |
| 63 | CDK19 | 1.08789405 |
| 64 | MST1R | 1.07883470 |
| 65 | KSR1 | 1.07535633 |
| 66 | CDK7 | 1.07291612 |
| 67 | EIF2AK1 | 1.07146556 |
| 68 | RIPK4 | 1.05223321 |
| 69 | MAP3K13 | 1.04448752 |
| 70 | CSNK1G1 | 1.03329563 |
| 71 | PKN2 | 1.02657125 |
| 72 | MAP3K3 | 1.01040699 |
| 73 | PDK3 | 1.00930986 |
| 74 | PDK4 | 1.00930986 |
| 75 | FGR | 0.99101401 |
| 76 | NME1 | 0.96858470 |
| 77 | MAP3K12 | 0.96633338 |
| 78 | CAMK2G | 0.94599423 |
| 79 | MAPK11 | 0.93937532 |
| 80 | CDK15 | 0.93614806 |
| 81 | KDR | 0.93479187 |
| 82 | MAP2K4 | 0.92836742 |
| 83 | CAMK2B | 0.91142218 |
| 84 | CDK18 | 0.90585838 |
| 85 | BUB1 | 0.89792316 |
| 86 | CLK1 | 0.89140578 |
| 87 | ERBB4 | 0.89099915 |
| 88 | SIK1 | 0.88349176 |
| 89 | MAP2K1 | 0.88304276 |
| 90 | FLT3 | 0.87333924 |
| 91 | RAF1 | 0.85035978 |
| 92 | TRIB3 | 0.83969493 |
| 93 | UHMK1 | 0.82764703 |
| 94 | CSNK1A1L | 0.82757491 |
| 95 | TESK1 | 0.82675257 |
| 96 | CDK11A | 0.82533941 |
| 97 | CDK5 | 0.81999836 |
| 98 | STK10 | 0.81908964 |
| 99 | LRRK2 | 0.81366765 |
| 100 | VRK2 | 0.77536585 |
| 101 | CAMKK2 | 0.77209868 |
| 102 | CSF1R | 0.77184092 |
| 103 | ROCK1 | 0.75867991 |
| 104 | ILK | 0.75222170 |
| 105 | CHEK2 | 0.74484938 |
| 106 | PRKCG | 0.73652534 |
| 107 | JAK3 | 0.73497259 |
| 108 | MAP3K4 | 0.72096030 |
| 109 | PAK1 | 0.71752322 |
| 110 | STK4 | 0.71480842 |
| 111 | AURKB | 0.71335954 |
| 112 | PRKD3 | 0.70900628 |
| 113 | ATR | 0.70627861 |
| 114 | AURKA | 0.70060071 |
| 115 | ZAP70 | 0.69996770 |
| 116 | ABL2 | 0.68504784 |
| 117 | TBK1 | 0.68297792 |
| 118 | BRAF | 0.67860286 |
| 119 | PKN1 | 0.67768290 |
| 120 | PNCK | 0.66957768 |
| 121 | MTOR | 0.66937614 |
| 122 | MAPKAPK5 | 0.65769793 |
| 123 | MAP2K2 | 0.65545258 |
| 124 | FGFR4 | 0.65225628 |
| 125 | CAMK2D | 0.64838997 |
| 126 | PIM2 | 0.63539339 |
| 127 | GRK6 | 0.62170399 |
| 128 | KIT | 0.62066082 |
| 129 | IRAK2 | 0.61688366 |
| 130 | NEK6 | 0.61594151 |
| 131 | WNK1 | 0.61446318 |
| 132 | DAPK1 | 0.60422048 |
| 133 | CAMK2A | 0.59945312 |
| 134 | PRKCE | 0.59167656 |
| 135 | CAMKK1 | 0.58472216 |
| 136 | PDK2 | 0.57888442 |
| 137 | FYN | 0.55900275 |
| 138 | TSSK6 | 0.55802170 |
| 139 | PDPK1 | 0.55762005 |
| 140 | PAK2 | 0.55417016 |
| 141 | IRAK4 | 0.55150027 |
| 142 | BTK | 0.54909633 |
| 143 | CHEK1 | 0.53962466 |
| 144 | EIF2AK3 | 0.52895162 |
| 145 | BMPR2 | 0.52722992 |
| 146 | MAP3K5 | 0.52534175 |
| 147 | MAPK13 | 0.51355373 |
| 148 | PRKCQ | 0.51178637 |
| 149 | TAOK2 | 0.51033221 |
| 150 | MAP3K6 | 0.50856714 |
| 151 | NEK2 | 0.50344464 |
| 152 | PDGFRA | 0.49874504 |
| 153 | STK16 | 0.49850352 |
| 154 | MAP3K1 | 0.48882912 |
| 155 | CCNB1 | 0.48581671 |
| 156 | PTK2 | 0.47959543 |
| 157 | PASK | 0.47942191 |
| 158 | PTK6 | 0.47197985 |
| 159 | FGFR1 | 0.45995118 |
| 160 | EPHA3 | 0.45148444 |
| 161 | MOS | 0.44334475 |
| 162 | TYK2 | 0.44047174 |
| 163 | MAPK12 | 0.42920647 |
| 164 | BMPR1B | 0.42830847 |
| 165 | ALK | 0.39650388 |
| 166 | FES | 0.39208468 |
| 167 | ITK | 0.37690734 |
| 168 | PLK4 | 0.37563919 |
| 169 | RPS6KC1 | 0.35261429 |
| 170 | RPS6KL1 | 0.35261429 |
| 171 | CDK2 | 0.34921460 |
| 172 | SYK | 0.34117523 |
| 173 | PIM1 | 0.33911383 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.13179509 |
| 2 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.23822448 |
| 3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.05364607 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.96269229 |
| 5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.79713631 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.77059777 |
| 7 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.59167132 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 2.53702515 |
| 9 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.52933757 |
| 10 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.36258291 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.30419540 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.30053688 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.26829241 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.26682790 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.25266886 |
| 16 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.24697847 |
| 17 | Mismatch repair_Homo sapiens_hsa03430 | 2.19723205 |
| 18 | Other glycan degradation_Homo sapiens_hsa00511 | 2.17323398 |
| 19 | Sulfur relay system_Homo sapiens_hsa04122 | 2.15963970 |
| 20 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.08857277 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.07568955 |
| 22 | Ribosome_Homo sapiens_hsa03010 | 2.05820136 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.99362460 |
| 24 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.96108138 |
| 25 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.92982625 |
| 26 | Spliceosome_Homo sapiens_hsa03040 | 1.92312806 |
| 27 | Cell cycle_Homo sapiens_hsa04110 | 1.86925890 |
| 28 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.76480552 |
| 29 | RNA transport_Homo sapiens_hsa03013 | 1.74007883 |
| 30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.73628284 |
| 31 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.69760650 |
| 32 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.69462170 |
| 33 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.68246185 |
| 34 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.52189287 |
| 35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.51658119 |
| 36 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.48586550 |
| 37 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.47465609 |
| 38 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.47381316 |
| 39 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.46343367 |
| 40 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.45114265 |
| 41 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.42801854 |
| 42 | Bladder cancer_Homo sapiens_hsa05219 | 1.39211676 |
| 43 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.38967463 |
| 44 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.36608484 |
| 45 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.35632414 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 1.34128155 |
| 47 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.34039767 |
| 48 | Peroxisome_Homo sapiens_hsa04146 | 1.31281602 |
| 49 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.30970783 |
| 50 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.28529357 |
| 51 | Carbon metabolism_Homo sapiens_hsa01200 | 1.28266374 |
| 52 | Proteasome_Homo sapiens_hsa03050 | 1.27003917 |
| 53 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.26775171 |
| 54 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.26487795 |
| 55 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.26412480 |
| 56 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.25096083 |
| 57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.25032207 |
| 58 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.24989251 |
| 59 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.24593042 |
| 60 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.20736973 |
| 61 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.20407436 |
| 62 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.17675855 |
| 63 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.13852424 |
| 64 | Thyroid cancer_Homo sapiens_hsa05216 | 1.13383379 |
| 65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.12480561 |
| 66 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.11107108 |
| 67 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.10472316 |
| 68 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.08879477 |
| 69 | Homologous recombination_Homo sapiens_hsa03440 | 1.06183782 |
| 70 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.04476127 |
| 71 | Lysosome_Homo sapiens_hsa04142 | 1.03644725 |
| 72 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.03563646 |
| 73 | Apoptosis_Homo sapiens_hsa04210 | 1.03463106 |
| 74 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.03377312 |
| 75 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.03180848 |
| 76 | Bile secretion_Homo sapiens_hsa04976 | 1.02851297 |
| 77 | Parkinsons disease_Homo sapiens_hsa05012 | 1.01049341 |
| 78 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.00049544 |
| 79 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.99964839 |
| 80 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.99893954 |
| 81 | * Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.97516138 |
| 82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.97215344 |
| 83 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.96309261 |
| 84 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.95220360 |
| 85 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.94780297 |
| 86 | Hepatitis B_Homo sapiens_hsa05161 | 0.94073792 |
| 87 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.93356358 |
| 88 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.93223612 |
| 89 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.92759588 |
| 90 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.89867440 |
| 91 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.89400588 |
| 92 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.87802564 |
| 93 | Retinol metabolism_Homo sapiens_hsa00830 | 0.86979024 |
| 94 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.86064706 |
| 95 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.85728200 |
| 96 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.84833466 |
| 97 | RNA polymerase_Homo sapiens_hsa03020 | 0.84353569 |
| 98 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.83833004 |
| 99 | GABAergic synapse_Homo sapiens_hsa04727 | 0.81071389 |
| 100 | Alzheimers disease_Homo sapiens_hsa05010 | 0.80527110 |
| 101 | HTLV-I infection_Homo sapiens_hsa05166 | 0.79867923 |
| 102 | Protein export_Homo sapiens_hsa03060 | 0.79739780 |
| 103 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.79664872 |
| 104 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.79652066 |
| 105 | Mineral absorption_Homo sapiens_hsa04978 | 0.79641687 |
| 106 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.79488100 |
| 107 | Viral myocarditis_Homo sapiens_hsa05416 | 0.77181843 |
| 108 | Measles_Homo sapiens_hsa05162 | 0.74465442 |
| 109 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.73116015 |
| 110 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.70406450 |
| 111 | Leishmaniasis_Homo sapiens_hsa05140 | 0.69891363 |
| 112 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.69890754 |
| 113 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.69485912 |
| 114 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.69318435 |
| 115 | Influenza A_Homo sapiens_hsa05164 | 0.68965036 |
| 116 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.68575722 |
| 117 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.67952940 |
| 118 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.64691519 |
| 119 | Purine metabolism_Homo sapiens_hsa00230 | 0.63821481 |
| 120 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.63623471 |
| 121 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.63534928 |
| 122 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.62732313 |
| 123 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61837036 |
| 124 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.61755810 |
| 125 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.61706011 |
| 126 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.61276873 |
| 127 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.60318266 |
| 128 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.59827388 |
| 129 | Salmonella infection_Homo sapiens_hsa05132 | 0.59717006 |
| 130 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.59180309 |
| 131 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.59152943 |
| 132 | Prion diseases_Homo sapiens_hsa05020 | 0.59039788 |
| 133 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.58653429 |
| 134 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.58570831 |
| 135 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.57422080 |
| 136 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.57218942 |
| 137 | Legionellosis_Homo sapiens_hsa05134 | 0.54783804 |
| 138 | Colorectal cancer_Homo sapiens_hsa05210 | 0.53111492 |
| 139 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.52950714 |
| 140 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.52783609 |
| 141 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.52580852 |
| 142 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.51818157 |
| 143 | Axon guidance_Homo sapiens_hsa04360 | 0.51423480 |
| 144 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51391451 |
| 145 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.50998277 |
| 146 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.49838663 |
| 147 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.49201128 |
| 148 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.49046970 |
| 149 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.47867423 |
| 150 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.47556453 |
| 151 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.46689289 |
| 152 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.46603603 |
| 153 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.46043155 |
| 154 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45375036 |
| 155 | Glioma_Homo sapiens_hsa05214 | 0.45319934 |
| 156 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.45018260 |
| 157 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.44056164 |
| 158 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43777173 |
| 159 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.42336160 |
| 160 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.41410079 |
| 161 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.41240005 |
| 162 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.41047609 |
| 163 | Nicotine addiction_Homo sapiens_hsa05033 | 0.39709238 |
| 164 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.39218448 |
| 165 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39118495 |
| 166 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.38963050 |
| 167 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.38616481 |
| 168 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38376054 |
| 169 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.38348852 |
| 170 | Tuberculosis_Homo sapiens_hsa05152 | 0.38030003 |
| 171 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.37708328 |
| 172 | Prostate cancer_Homo sapiens_hsa05215 | 0.36102488 |
| 173 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35839279 |
| 174 | Endocytosis_Homo sapiens_hsa04144 | 0.35754864 |
| 175 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.30356596 |
| 176 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.27355901 |
| 177 | Huntingtons disease_Homo sapiens_hsa05016 | 0.26177723 |
| 178 | Long-term depression_Homo sapiens_hsa04730 | 0.25896639 |
| 179 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.23219779 |

